The conversational AI firm's shares surged on massive volume without a clear fundamental catalyst, pointing to a potential short squeeze or social media-driven rally.
Investor concerns over shareholder dilution intensify after the biotech company closes a $4.8 million capital raise to fund operations.
Investors are closely watching the beverage giant's Q3 results on Monday for insights into the health of the alcoholic beverage market.
State tech hub funding and an expanded partnership with Ember Recreational Vehicles fuel investor optimism in the battery manufacturer.
First patients implanted with the novel neurostimulator marks a key step in challenging market leader Inspire Medical after recent FDA approval.
The designation for ALTO-101 targets cognitive impairment, a debilitating condition with no currently approved treatments, signaling a major regulatory milestone.
A potential leadership reshuffle at the tech giant reportedly positions hardware engineering chief John Ternus to eventually succeed Tim Cook.
Conditional approval for Dectomax-CA1 addresses a significant threat to the U.S. livestock industry, boosting company shares.